Protective role of antidiabetic drug metformin against gentamicin induced apoptosis in auditory cell line

Hearing Research

Volumn 282, Issue 1-2, 2011, Pages 92-96

  Jung, Hak Hyun ^a   Chang, Jiwon ^a   Yang, Ji Yoon ^a   Choi, June ^a   Im, Gi Jung ^a   Chae, Sung Won ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOCHROME C; GENTAMICIN; METFORMIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUDITORY SYSTEM; CALCIUM CELL LEVEL; CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; MOUSE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CALCIUM; CASPASE 3; CELL LINE; CELL SURVIVAL; CYTOPROTECTION; GENTAMICINS; HYPOGLYCEMIC AGENTS; METFORMIN; MICE; MOLECULAR IMAGING; ORGAN OF CORTI; POLY(ADP-RIBOSE) POLYMERASES; REACTIVE OXYGEN SPECIES;

EID: 82755160613     PISSN: 03785955     EISSN: 18785891     Source Type: Journal    
DOI: 10.1016/j.heares.2011.09.005     Document Type: Article

References (27)

1. Argaud D., Roth H., Wiernsperger N., Leverve X.M. Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes. Eur J Biochem 1993, 213:1341-1348.
2. Bernardi P., Krauskopf A., Basso E., Petronilli V., Blachly-Dyson E., Di Lisa F., et al. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J 2006, 273:2077-2099.
3. Bernardi P., Scorrano L., Colonna R., Petronilli V., Di Lisa F. Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem 1999, 264:687-701.
4. Dehne N., Rauen U., de Groot H., Lautermann J. Involvement of the mitochondrial permeability transition in gentamicin ototoxicity. Hear Res 2002, 169:47-55.
5. Ding D., Stracher A., Salvi R. Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity. Hear Res 2002, 164:115-126.
6. El-Mir M.Y., Detaille D., Villanueva G.R., et al. Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons. J Mol Neurosci 2008, 34:77-87.
7. Fontaine E., Eriksson O., Ichas F., Bernardi P. Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation by electron flow through the respiratory chain complex I. J Biol Chem 1998, 273:12662-12668.
8. Guigas B., Detaille D., Chauvin C., et al. Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study. Biochem J 2004, 382:877-884.
9. Hirose K., Westrum L.E., Stone J.S., Zirpel L., Rubel E.W. Dynamic studies of ototoxicity in mature avian auditory epithelium. Ann N Y Acad Sci 1999, 884:389-409.
10. Hundal H.S., Ramlal T., Reyes R., Leiter L.A., Klip A. Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology 1992, 131:1165-1173.
11. Hundal R.S., Krssak M., Dufour S., Laurent D., Lebon V., Chandramouli V., Inzucchi S.E., Schumann W.C., Petersen K.F., Landau B.R., et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 2000, 49:2063-2069.
12. Jacotot E., Costantini P., Laboureau E., Zamzami N., Susin S.A., Kroemer G. Mitochondrial membrane permeabilization during the apoptotic process. Ann N Y Acad Sci 1999, 887:18-30.
13. Kalkandelen S., Selimoglu E., Erdogan F., Ucuncu H., Altas E. Comparative cochlear toxicities of streptomycin, gentamicin, amikacin and netilmicin in guinea-pigs. J Int Med Res 2002, 30:406-412.
14. Kalinec G.M., Webster P., Lim D.J., Kalinec F. A cochlear cell line as an in vitro system for drug ototoxicity screening. Audiol Neurootol 2003, 8:177-189.
15. Lablanche S., Cottet-Rousselle C., Lamarche F., Benhamou P.-Y., Halimi S., Leverve X., Fontaine E. Protection of pancreatic INS-1 b-cells from glucose- and fructose-induced cell death by inhibiting mitochondrial permeability transition with cyclosporine A or metformin. Cell Death Dis Mar 2011, 24(2):e134.
16. Lustig L.R. The history of intratympanic drug therapy in otology. Otolaryngol Clin North Am 2004, 37:1001-1017.
17. ++ changes in human lung mast cells: graded vs. all-or-nothing elevations after IgE-mediated stimulation. J Cell Biol 1989, 109:123-134.
18. McMurtrie E.B., Barbosa M.D., Zerial M., Kingsmore S.F. Rab17 and rab18, small GTPases with specificity for polarized epithelial cells: genetic mapping in the mouse. Genomics 1997, 45:623-625.
19. Morales A.I., Detaile D., Prieto M., Puente A., Briones E., Arevalo M., Leverve X., López-Novoa J.M., El-Mir M.Y. Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway. Kidney Int May 2010, 77(10):861-869.
20. Nedzelski J.M., Schessel D.A., Bryce G.E., et al. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Ménière's disease. Am J Otol 1992, 13:18-22.
21. Roland J.T., Cohen N.L. Vestibular and auditory ototoxicity. Otolaryngology & Head and Neck Surgery 1998, 3186-3197. Mosby, St. Louis. third ed. C.W. Cummings, J.M. Frederickson, L.A. Harker, C.J. Krause, D.F. Schuller, M.A. Richardson (Eds.).
22. Roland P.S. New developments in our understanding of ototoxicity. Ear Nose Throat J 2004, 83:15-16.
23. Rybak L.P., Kelly T. Ototoxicity: bioprotective mechanisms. Curr Opin Otolaryngol Head Neck Surg 2003, 11:328-333.
24. Selimoglu E. Aminoglycoside-induced ototoxicity. Curr Pharm Des 2007, 13(1):119-126.
25. Selimoglu E., Kalkandelen S., Erdogan F. Comparative vestibulotoxicity of different aminoglycosides in the guinea pigs. Yonsei Med J 2003, 44:517-522.
26. Strupp M., Arbusow V. Acute vestibulopathy. Curr Opin Neurol 2001, 14:11-20.
27. Zhou G., Li Y., Myers R., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Jujji N., Musi N., Hirshman M.F., Goodyear L.J., Mooer D.E. Role of AMP-activated proten kinase in mechanism of metformin action. J Clin Invest 2001, 108:1167-1174.